Gilde raises €85 million for second health care fund

By Elaine Rigoli

Tampa, Fla., July 5 - Gilde Healthcare Partners announced the first closing of Gilde Healthcare 2 (GHC 2), its second life science venture fund.

Current commitments to GHC 2 amount to €85 million. Further closes are anticipated later in 2006.

The fund expects to reach a final close of at least €125 million.

GHC 2 will invest principally in unquoted European start-ups and broadly across the health care sector including therapeutics, diagnostics, medical devices and enabling technologies.

Investment size will range between €1 million to €12 million per portfolio company, according to a news release.

"This is a very satisfying result in what is generally regarded as a challenging fundraising environment. We are delighted to have attracted such significant support from both new and existing investors and expect to announce further commitments to GHC 2 soon," managing director Pieter van der Meer said in the release.

Gilde is a life sciences venture capital group based in Utrecht, the Netherlands.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.